This Article Free Full Text (Free PDF) Free All Versions of this Article: 0009922807303224v1 46/9/777    most recent References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (2) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Cogen, F. R. Articles by Streisand, R. Search for Related Content PubMed PubMed Citation Articles by Cogen, F. R. Articles by Streisand, R. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Diabetes Type 1 Social Bookmarking                         What's this?

Pediatric Quality of Life in Transitioning to the Insulin Pump: Does Prior Regimen Make a Difference?

Division of Endocrinology and Diabetes, Department of Pediatrics, Washington University

Celia Henderson, RN, CDE

Division of Endocrinology and Diabetes, Department of Pediatrics, Washington University

Jennifer A. Hansen, MA

Departments of Psychiatry and Behavioral Sciences and of Pediatrics, Children's National Medical Center and the George Washington University School of Medicine and Health Sciences, Washington, District of Columbia

Randi Streisand, PhD, CDE

Departments of Psychiatry and Behavioral Sciences and of Pediatrics, Children's National Medical Center and the George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, rstreis{at}cnmc.org

A shift in conventional diabetes management has graduated to basal (glargine) and bolus (rapid-acting analogue) therapy via multiple daily injections or continuous subcutaneous insulin infusion (CSII). Continuous subcutaneous insulin infusion is considered the most intensive type of diabetes management, and before transitioning, consideration of regimen benefits should include lifestyle and quality-of-life issues in addition to medical benefits. Short-term and long-term changes in children's quality of life, as a function of their pre-CSII diabetes regimen, was assessed in 52 children before their transition to CSII from a conventional or multiple daily injection regimen. Results demonstrated significant improvement in quality of life only for those children transitioning to CSII from conventional vs multiple daily injection regimens; results were maintained at 6 months following pump initiation. Quality of life is an important consideration as children transition from more traditional to intensive regimens, and CSII devices may not necessarily improve satisfaction with diabetes control in all pediatric patients. Risks and benefits of both intensive regimens should be discussed before making the transition.

Key Words: type 1 diabetes mellitus • pump • Lantus • NPH/regular • quality of life • insulin regimen

This version was published on December 1, 2007

Clinical Pediatrics, Vol. 46, No. 9, 777-779 (2007)
DOI: 10.1177/0009922807303224


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J. Weissberg-Benchell, T. Nansel, G. Holmbeck, R. Chen, B. Anderson, T. Wysocki, L. Laffel, and For the Steering Committee of the Family Managemen Generic and Diabetes-specific Parent-Child Behaviors and Quality of Life Among Youth with Type 1 Diabetes J. Pediatr. Psychol., October 1, 2009; 34(9): 977 - 988. [Abstract] [Full Text] [PDF]

				M. E. Hilliard, M. Goeke-Morey, F. R. Cogen, C. Henderson, and R. Streisand Predictors of Diabetes-related Quality of Life after Transitioning to the Insulin Pump J. Pediatr. Psychol., March 1, 2009; 34(2): 137 - 146. [Abstract] [Full Text] [PDF]